购物车
- 全部删除
- 您的购物车当前为空
Istaroxime hydrochloride (PST2744 hydrochloride) 是 Na+/K+-ATPase 抑制剂和肌浆/内质网钙ATP酶2 (SERCA 2) 激活剂,是一种新型正性肌力化合物,可用于研究急性心力衰竭。
Istaroxime hydrochloride (PST2744 hydrochloride) 是 Na+/K+-ATPase 抑制剂和肌浆/内质网钙ATP酶2 (SERCA 2) 激活剂,是一种新型正性肌力化合物,可用于研究急性心力衰竭。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 1,060 | 现货 | |
5 mg | ¥ 1,790 | 5日内发货 | |
25 mg | ¥ 5,930 | 6-8周 | |
50 mg | ¥ 7,710 | 6-8周 | |
100 mg | ¥ 11,600 | 6-8周 | |
1 mL x 10 mM (in DMSO) | ¥ 1,560 | 5日内发货 |
产品描述 | Istaroxime hydrochloride (PST2744 hydrochloride) is a Na+/K+-ATPase inhibitor and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA 2) activator, a novel positive inotropic compound that can be used to study acute heart failure. |
靶点活性 | Na+, K+-ATPase:0.11 μM, Na+/K+-ATPase (dog kidney):0.43 μM, Na+/K+-ATPase (guinea-pig kidney):8.5 μM |
体外活性 | Istaroxime hydrochloride 作为一种正性肌力药物,通过抑制 Na+,K+-ATPase 发挥作用。[1] Istaroxime hydrochloride 在狗肾中抑制 Na+/K+-ATPase 活性的 IC50 值为 0.43 μM。而在豚鼠肾组织制备物中,Istaroxime hydrochloride 抑制 Na+/K+-ATPase 活性的效力为 8.5 μM。[2] |
体内活性 | Istaroxime hydrochloride 在整个输注期间逐步提升 +dP/dtmax,在累计剂量为 1.89 mg/kg时达到80%的效果(ED80),并在剂量增至 4.88mg/kg 时(EDmax),效果峰值达到 140%。[2] |
别名 | 伊司他肟盐酸, ST-2744 hydrochloride, PST-2744 hydrochloride, PST2744 hydrochloride, PST 2744 hydrochloride, Istaroxime HCl |
分子量 | 396.95 |
分子式 | C21H33ClN2O3 |
CAS No. | 374559-48-5 |
Smiles | C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)C(=O)CC4)[H])(CC(=O)[C@]1(CC(=NOCCN)CC2)[H])[H])[H].Cl |
密度 | no data available |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | H2O: 20 mg/mL(50.38 mM), Sonication is recommended. DMSO: 40 mg/mL(100.77 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容